Literature DB >> 10401559

Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage.

D Salvemini1, D P Riley, P J Lennon, Z Q Wang, M G Currie, H Macarthur, T P Misko.   

Abstract

1. The relative contributions of superoxide anion (O2-) and peroxynitrite (PN) were evaluated in the pathogenesis of intestinal microvascular damage caused by the intravenous injection of E. coli lipopolysaccharide (LPS) in rats. The superoxide dismutase mimetic (SODm) SC-55858 and the active peroxynitrite decomposition catalysts 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulphonatophenyl)-por phyrinato iron (III) and 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)-porphyrinato iron (III) (FeTMPS, FeTMPyP respectively) were used to assess the roles of O2- and PN respectively. 2. The intravenous injection of LPS elicited an inflammatory response that was characterized by a time-dependent infiltration of neutrophils, lipid peroxidation, microvascular leakage (indicative of microvascular damage), and epithelial cell injury in both the duodenum and jejunum. 3. Administration of the SODm SC-55858, FeTMPS or FeTMPyP at 3 h post LPS reduced the subsequent increase in microvascular leakage, lipid peroxidation and epithelial cell injury. Inactive peroxynitrite decomposition catalysts exhibited no protective effects. Only, SC-55858 inhibited neutrophil infiltration. 4. Our results suggest that O2 and peroxynitrite play a significant role in the pathogenesis of duodenal and intestinal injury during endotoxaemia and that their remoyal by SODm and peroxynitrite decomposition catalysts offers a novel approach to the treatment of septic shock or clinical conditions of gastrointestinal inflammation. Furthermore, the remarkable protection of the intestinal epithelium by these agents suggests their use during chemo- and radiation therapy, cancer treatments characterized by gastrointestinal damage. Potential mechanisms through which these radicals evoke damage are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401559      PMCID: PMC1566068          DOI: 10.1038/sj.bjp.0702604

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  The role of peroxynitrite in nitric oxide-mediated toxicity.

Authors:  J P Crow; J S Beckman
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 2.  Nitric oxide: role in neurotoxicity.

Authors:  V L Dawson
Journal:  Clin Exp Pharmacol Physiol       Date:  1995-04       Impact factor: 2.557

3.  Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.

Authors:  D Salvemini; P T Manning; B S Zweifel; K Seibert; J Connor; M G Currie; P Needleman; J L Masferrer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors.

Authors:  D Lamarque; B J Whittle
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Superoxide scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in mammalian cells.

Authors:  P R Gardner; D D Nguyen; C W White
Journal:  Arch Biochem Biophys       Date:  1996-01-01       Impact factor: 4.013

6.  Reactive oxygen species produced by liver mitochondria of rats in sepsis.

Authors:  D E Taylor; A J Ghio; C A Piantadosi
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

Review 7.  Nitric oxide synthase: expression and expressional control of the three isoforms.

Authors:  U Förstermann; H Kleinert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

8.  A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro.

Authors:  B J Day; S Shawen; S I Liochev; J D Crapo
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

9.  Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors.

Authors:  D Lamarque; B J Whittle
Journal:  Eur J Pharmacol       Date:  1995-04-24       Impact factor: 4.432

10.  Assessment of myeloperoxidase activity in renal tissue after ischemia/reperfusion.

Authors:  D W Laight; N Lad; B Woodward; J F Waterfall
Journal:  Eur J Pharmacol       Date:  1994-11-01       Impact factor: 4.432

View more
  30 in total

Review 1.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 2.  Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

Authors:  Srikanth Santhanam; David M Alvarado; Matthew A Ciorba
Journal:  Transl Res       Date:  2015-08-03       Impact factor: 7.012

3.  Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.

Authors:  S Cuzzocrea; E Mazzon; L Dugo; A P Caputi; K Aston; D P Riley; D Salvemini
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 4.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

5.  Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo.

Authors:  W Qi; K V J Ebbert; A W B Craig; P A Greer; D-M McCafferty
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

6.  Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine.

Authors:  Ahmet Guven; Turan Tunc; Turgut Topal; Mustafa Kul; Ahmet Korkmaz; Gokhan Gundogdu; Onder Onguru; Haluk Ozturk
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

7.  Superoxide and Nitric Oxide Involvement in Enhancing of N-methyl-D-aspartate Receptor-Mediated Central Sensitization in the Chronic Post-ischemia Pain Model.

Authors:  Tae Ha Ryu; Kyung Young Jung; Mi Jin Ha; Kyung Hwa Kwak; Dong Gun Lim; Jung Gil Hong
Journal:  Korean J Pain       Date:  2010-03-10

Review 8.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

9.  Protein nitration in cutaneous inflammation in the rat: essential role of inducible nitric oxide synthase and polymorphonuclear leukocytes.

Authors:  S A B Greenacre; F A C Rocha; A Rawlingson; S Meinerikandathevan; R N Poston; E Ruiz; B Halliwell; S D Brain
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Emanuela Mazzon; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-17       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.